Make No Mistake: Patentee Held to Terminal Disclaimer Despite Unwitting Reliance on Patent Office Error

July 23, 2024

Reading Time : 2 min

A court in the Western District of Oklahoma dismissed a complaint as to one of the asserted patents where the patent included a terminal disclaimer stating that the patent would be enforceable only as long as it was co-owned with a reference patent that the PTO had misidentified. The court relied on the public notice function of the patent system to hold the plaintiff to the exact language in its terminal disclaimer, and held that the asserted patent was unenforceable from the moment it issued because it and the reference patent were never co-owned.

During prosecution, the PTO rejected the claims of the asserted patent on obviousness-type double patenting grounds over the ’267 patent. But the ’267 patent was directed to completely different subject matter and owned by a different entity. Nonetheless, plaintiff overcame that rejection by filing a terminal disclaimer stating that the asserted patent and the ’267 patent were commonly owned by plaintiff and agreeing that the asserted patent would be enforceable only during such period that it and the ’267 patent were commonly owned. But plaintiff never owned the ’267 Patent. It did own the ’268 patent, which was in the same family as the asserted patent, but not mentioned in the office action. Several years after the PTO issued the asserted patent, plaintiff petitioned to withdraw the ’267 disclaimer and replace it with a new terminal disclaimer based on the ’268 patent. The PTO denied the request to withdraw but allowed plaintiff to file a new terminal disclaimer with respect to the ’268 patent.

In its motion to dismiss, defendant argued that the terms of the terminal disclaimer were clear: the asserted patent would be enforceable only while it and the ’267 patent were commonly owned. And because the two patents were never commonly owned, the asserted patent was never enforceable. Plaintiff explained that the ’267 terminal disclaimer was ineffective because it was disconnected from the purpose of a terminal disclaimer—to resolve an obviousness-type double patenting issue. Plaintiff further argued that regulations bar a patent applicant from filing a terminal disclaimer to a patent that it does not commonly own. Finally, plaintiff argued that the mistake would be obvious to anyone reading the prosecution history of the patent.

The court acknowledged the dearth of opinions addressing an erroneous terminal disclaimer, but explained that the public is entitled to rely on the clear terms in a patentee’s terminal disclaimer.  Here, the patentee gave notice to the public that the asserted patent was unenforceable so long as it was commonly owned with the ’267 patent. The two patents were never commonly owned, and the court could not assume no member of the public ever relied on the ’267 patent disclaimer.  The court was not persuaded that the mistake was obvious because even the patentee itself did not notice the error for years. Because the ’267 disclaimer rendered the asserted patent unenforceable, the court granted defendant’s motion to dismiss.

Practice Tip: Patent applicants should carefully review both the PTO’s obviousness-type double patenting rejections and their own terminal disclaimers to ensure that there are no errors. The public notice function of the patent system could lead a court to strictly interpret a terminal disclaimer as it is written, even if it refers to a patent that the PTO had erroneously identified.

SIPCO, LLC v. Jasco Prods. Co., LLC, No. CIV-19-00709-PRW (W.D. Okla. May 29, 2024)

Share This Insight

Previous Entries

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

IP Newsflash

January 17, 2025

The District of Arizona recently held that a plaintiff’s failure to mark patented products during the time period that marking was required barred it from recovering all pre-notice damages, including for a period of time when there was no obligation to mark.

...

Read More

IP Newsflash

January 16, 2025

The Unified Patent Court (UPC) aims to provide expeditious decisions for its litigants. That means that there is a higher bar for obtaining extensions of time. As exemplified in BMW v. ITCiCo, the UPC’s reluctance to grant extensions can have serious consequences, including revocation of the patent.

...

Read More

IP Newsflash

January 15, 2025

The Patent Trial and Appeal Board granted institution of inter partes review of a patent directed to delivery of targeted television advertisements. The board rejected patent owner’s argument that a lack of particularity as to the asserted grounds justified denial under 35 U.S.C. § 312(a), holding that “simply including a significant amount of testimony and a number of supporting references is not, by itself, a reason to find that the particularity requirement is not met.”

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.